Ebola Spurs Creation of Japan’s First Maximum-Security Biolab
Original article from: Nature posted on August 13, 2015. by Helen Shen
Japan is set to join an elite and dangerous club with its decision to upgrade an existing infectious-disease lab to handle the most hazardous pathogens. The move sweeps away more than three decades of political opposition to operating a top-biosafety-level facility 30 kilometres west of Tokyo in the city of Musashi-Murayama.
An agreement reached on 3 August between Japan’s health ministry and the mayor of Musashi-Murayama clears the way for the facility to begin limited work with BSL-4 pathogens such as the Lassa and Ebola viruses. Japan’s National Institute of Infectious Diseases (NIID) built the biosafety-level-4 (BSL-4) lab in 1981, but it has been limited to operating as a BSL-3 lab because of safety concerns. Fears that Ebola might reach Japan during last year’s outbreak in West Africa partly motivated the policy change.
The deal sets several conditions for the lab’s activities: the NIID has committed to maintain transparency in reporting lab operations and any accident, and the lab must also restrict its BSL-4 work to diagnosing and treating patients instead of a broader research programme. However, virologist Ayato Takada at Hokkaido University in Sapporo, Japan, hopes that the agreement will ease the way for other facilities where scientists can perform basic infectious disease research at the BSL-4 level. Discussions are under way to build a bigger and more modern BSL-4 lab at Nagasaki University — a move that has similarly met with community opposition.